← All candidates
Two insider buys in the last year — $2.35M in all.
60 filings on record.
KURAKura Oncology, Inc.
NasdaqGS · Healthcare · $996.36M
$11.20
-0.88% · Sep 16
Two insider buys in the last year — $2.35M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys● 36 sells◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$996.36M
Float
70.4M
79% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
12.9
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
President and CEO
Wilson Troy Edward
Bought $1.24M on Aug 24 — 100,000 sh @ $12.39, held indirect, 21% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
55 more transactions on Pro →Context
Wall St
$32.00 avg target
+185.7% vs today · 12 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 3 quarters beat
Q2 '26−$0.77 act+$0.11
Q4 '25−$0.92 act−$0.43
Q3 '25−$0.85 act−$0.17
The file stays open
60 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice